PHS
ALGN icon

PFM Health Sciences’s Align Technology ALGN Stock Holding History

PFM Health Sciences’s Portfolio ALGN Stock Details ALGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,304
Closed -$6.61M – 85
2025
Q4 		$6.61M Buy
+42,304
New +$6.06M 0.66% 47
2024
Q2 		– Sell
-22,751
Closed -$7.46M – 79
2024
Q1 		$7.46M Buy
+22,751
New +$6.67M 0.35% 58
2019
Q3 		– Sell
-155,459
Closed -$42.5M – 73
2019
Q2 		$42.5M Sell
155,459
-57,430
-27% -$17.3M 0.81% 43
2019
Q1 		$60.5M Sell
212,889
-24,359
-10% -$5.81M 1.34% 29
2018
Q4 		$49.7M Buy
+237,248
New +$59.9M 1.32% 29
2013
Q3 		– Sell
-380,020
Closed -$14.1M – 73
2013
Q2 		$14.1M Buy
+380,020
New +$13.1M 0.29% 56

Other funds holding ALGN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PFM Health Sciences's ALGN Position: Q1 2026 in Review

PFM Health Sciences sold out of Align Technology (ALGN) in Q1 2026, closing a stake of 42,304 shares — an estimated $6.61M sold.

PFM Health Sciences first reported a position in ALGN in Q2 2013 and held it in 6 quarters. The position peaked at $60.5M in Q1 2019. 693 funds tracked by Wall St. Rank hold ALGN as of Q1 2026.

  • PFM Health Sciences reported no remaining Align Technology position as of Q1 2026 after selling out during the quarter.
  • PFM Health Sciences sold 42,304 Align Technology shares in Q1 2026, an estimated $6.61M.
  • PFM Health Sciences first reported a position in Align Technology in Q2 2013 and held it in 6 quarters.
  • PFM Health Sciences's Align Technology position peaked at $60.5M in Q1 2019.
  • 693 funds tracked by Wall St. Rank held Align Technology as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.